| Cat. No. |
Product Name |
Information |
| PC-24155 |
Milpecitinib
JAK inhibitor
|
Milpecitinib is potent, selective Janus tyrosine kinase (JAK) inhibitor. |
| PC-24148 |
Lirucitinib hydrochloride
JAK inhibitor
|
Lirucitinib hydrochloride is a potent, selective JAK inhibitor. |
| PC-24147 |
Lirucitinib
JAK inhibitor
|
Lirucitinib is a potent, selective JAK inhibitor. |
| PC-23784 |
Dual JAK3-TEC kinase inhibitor ZZB
JAK3/TEC kinase inhibitor
|
Dual JAK3-TEC kinase inhibitor ZZB is a potent, selective, covalent dual JAK3/TEC family kinases inhibitor with IC50 of 0.80 nM against JAK3 and 11.56 nM against TEC kinase interleukin-2-inducible T-cell kinase (ITK) respectively. |
| PC-22994 |
SB1578
JAK2/FLT3 inhibitor
|
SB1578 is a potent, selective JAK2/FLT3 inhibitor with IC50 of 46/60 nM respectively. |
| PC-22718 |
Coumermycin A1
JAK2 agonist
|
Coumermycin A1 (C-A1) is a small molecule JAK2 agonist that induces dimerization and activation of JAK2, also inhibits DNA Gyrase and cell division in bacteria. |
| PC-22634 |
CS12192
JAK//TBK1 inhibitor
|
CS12192 is a potent, selective JAK3/JAK1/TBK1 inhibitor with IC50 of 11/105/162 nM, respectively. |
| PC-22618 |
Oclacitinib maleate
JAK inhibitor
|
Oclacitinib (PF-03394197) maleate is a potent JAK inhibitor with IC50 of 10, 18, 99, and 84 nM for JAK1, JAK2, JAK3, and TYK2, respectively. |
| PC-22495 |
MS-1020
JAK3 inhibitor
|
MS-1020 is a selective, ATP-competitive small molecule JAK3 inhibitor, directly blocks JAK3 catalytic activity, potently inhibits persistently-active STAT3 in a cell type-specific manner. |
| PC-22202 |
JAK3 inhibitor RB1
JAK3 inhibitor
|
JAK3 inhibitor RB1 is a potent, selective and irreversible JAK3 inhibitor with IC50 of 40 nM, without inhibiting JAK1, JAK2 or TYK2 (IC50>5000 nM). |
| PC-21900 |
CEP-33779
JAK2 inhibitor
|
CEP-33779 is a potent, selective, and orally bioavailable inhibitor of JAK2 with IC50 of 1.3 nM, 65-fold selective over JAK-3. |
| PC-21596 |
JNJ-64251330
JAK inhibitor
|
Lorpucitinib (JNJ-64251330) is potent, selective and orally bioavailable pan-JAK inhibitor with IC50 of 0.37/8.6/92/7.4 nM for JAK1/JAK2/JAK3/Tyk2 respectively. |
